| 000 | 01551 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513001736.0 | ||
| 264 | 0 | _c19820412 | |
| 008 | 198204s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(19820215)49:4<708::aid-cncr2820490419>3.0.co;2-a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRambotti, P | |
| 245 | 0 | 0 |
_aCell membrane markers and phytohemagglutinin reactivity of circulating lymphocytes from chronic myelocytic leukemia patients. _h[electronic resource] |
| 260 |
_bCancer _cFeb 1982 |
||
| 300 |
_a708-13 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCell Membrane _ximmunology |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid _xdrug therapy |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 |
_aLymphocytes _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPhytohemagglutinins _xpharmacology |
| 650 | 0 | 4 | _aRosette Formation |
| 650 | 0 | 4 | _aSplenectomy |
| 700 | 1 | _aLiberati, A M | |
| 700 | 1 | _aVelardi, A | |
| 700 | 1 | _aBallatori, E | |
| 700 | 1 | _aMartelli, M F | |
| 700 | 1 | _aGrignani, F | |
| 700 | 1 | _aDavis, S | |
| 773 | 0 |
_tCancer _gvol. 49 _gno. 4 _gp. 708-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19820215)49:4<708::aid-cncr2820490419>3.0.co;2-a _zAvailable from publisher's website |
| 999 |
_c6948285 _d6948285 |
||